Decipher Biosciences, Inc.

90 articles about Decipher Biosciences, Inc.

• GenomeDx Biosciences Announces New York State CLEP Approval Of Decipher Prostate Cancer Tests

  6/29/2017

• GenomeDx Biosciences Release: Multiple Studies Further Validate The Importance Of Decipher Post-Op In The Treatment Of Prostate Cancer

  6/7/2017

• GenomeDx Biosciences And Color Collaborate To Further Advance Precision Medicine For Prostate Cancer Patients And Their Families

  5/12/2017

• GenomeDx Biosciences's Decipher GRID Aids In Development And Validation Of Molecular Subtypes In Prostate Cancer That Predict Response To Hormone Therapy

  5/11/2017

• GenomeDx Biosciences Launches Decipher Bladder Cancer Classifier Following Publication Of Study On Development, Validation Of Molecular Subtyping In Muscle-Invasive Bladder Cancer Patients

  5/10/2017

• GenomeDx Biosciences Appoints Michael Rodriguez As Chief Financial Officer

  5/9/2017

• GenomeDx Biosciences's Decipher Post-Op Demonstrates Positive Impact On Physician, Patient Treatment Decisions In Multicenter Prospective Study

  4/25/2017

• GenomeDx Biosciences Announces Initiation By Michigan Urological Surgery Improvement Collaborative

  3/2/2017

• GenomeDx Biosciences Announces Research Collaboration With Astellas To Identify Genomic Drivers Of Patient Response To XTANDI (Enzalutamide) Capsules

  2/1/2017

• GenomeDx Biosciences Release: Diagnostic Company's Decipher Biopsy Demonstrates Ability To Predict Metastasis After Radiation And Androgen Deprivation Therapy In Prostate Cancer Patients

  1/25/2017

• GenomeDx Biosciences's Decipher GRID Aids In Development And Validation Of The First Molecular Signature To Predict Response To Radiotherapy In Prostate Cancer

  10/19/2016

• GenomeDx Biosciences And Bostwick Laboratories Announce Marketing Agreement For Decipher Prostate Cancer Classifier Test

  10/4/2016

• GenomeDx Biosciences Launches Expanded GRID Tumor Profiling To Provide Enhanced Genomic Understanding Of Patients' Prostate Cancer

  9/29/2016

• GenomeDx Biosciences And SouthGenetics Announce Strategic Agreement For Latin America Commercialization

  9/28/2016

• GenomeDx Biosciences's Decipher GRID And Decipher Tests To Be Featured In Multiple Presentations At ASTRO 2016

  9/22/2016

• GenomeDx Biosciences Adds Multiple Leading Cancer Centers To Its Proprietary Genomics Resource Information Database Platform (Decipher GRID)

  9/13/2016

• Prospective Study Shows GenomeDx Biosciences's Decipher Cancer Classifier Significantly Reclassifies Tumor Aggressiveness

  9/6/2016

• GenomeDx Biosciences Receives Accreditation From College of American Pathologists

  7/6/2016

• GenomeDx Biosciences's Decipher GRID And Decipher Tests To Be Featured In Multiple Presentations At ASCO 2016

  5/23/2016

• GenomeDx Biosciences Release: Decipher Prostate Cancer Test Guides Timing Of Postoperative Radiotherapy

  5/19/2016